
FierceBiotech
Jul 9, 2021 9:30am
“Immix Bio, focused on tissue-specific therapeutics for oncology and inflammation, chose Gabriel Morris as its chief financial officer and board member.”
FierceBiotech
Jul 9, 2021 9:30am
“Immix Bio, focused on tissue-specific therapeutics for oncology and inflammation, chose Gabriel Morris as its chief financial officer and board member.”
Categories:
Tags: